The findings, published in the Journal of Nutrition, come from the extension of a 12-month study on 157 adults. It found that a daily intake of 3.4g of CLA, produced an average 9 per cent reduction in body fat mass.
While the second year of study was not carried out in double-blind conditions, and therefore cannot provide such strong evidence of efficacy, it does reflect high compliance levels for the product and its long-term safety.
“The high compliance and low drop-out rates indicate that long-term CLA supplementation was well-tolerated by subjects,” write the authors.
After the initial 12 month trial, published last spring in the American Journal of Clinical Nutrition, 134 of the participants volunteered to continue for another 12 months. Ethical reasons stopped the researchers from continuing the double-blind procedure.
CLA supplementation also appeared to lower levels of leptin, a hormone associated with increased weight. Over the course of 24 months, leptin levels dropped 20-35 per cent as study subjects lost body fat.
The researchers say that risk of side effects from CLA is no greater than in those taking the placebo.
No comments:
Post a Comment